An effective covid-19 vaccine is a turning point in the pandemic
It is a breakthrough for the history books. But a lot still needs to be done
Editor’s note: Some of our covid-19 coverage is free for readers of The Economist Today, our daily newsletter. For more stories and our pandemic tracker, see our hub
DELIVERANCE, WHEN it arrives, will come in a small glass vial. First there will be a cool sensation on the upper arm as an alcohol wipe is rubbed across the skin. Then there will be a sharp prick from a needle. Twenty-one days later, the same again. As the nurse drops the used syringe into the bin with a clatter, it will be hard not to wonder how something so small can solve a problem so large.
This article appeared in the Briefing section of the print edition under the headline "Bullseye"
From the November 12th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Briefing
America’s $61bn aid package buys Ukraine time
It must use it wisely
America is uniquely ill-suited to handle a falling population
Which is a worry, because much of it is already shrinking
Homeowners face a $25trn bill from climate change
Property, the world’s biggest asset class, is also its most vulnerable